Long-term clinical outcome of patients treated with β-brachytherapy in routine clinical practice

International Journal of Cardiology

Volumn 115, Issue 2, 2007, Pages 183-189

  Nikas, Dimitrios N ^a   Kalef Ezra, John ^b   Katsouras, Christos S ^a   Tsekeris, Periklis ^a   Bozios, George ^b   Pappas, Christos ^a   Naka, Katerina K ^a   Kotsia, Anna ^b   Papamichael, Nikolaos ^b   Sideris, Dimitrios A ^a   Michalis, Lampros K ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Brachytherapy; Intravascular brachytherapy; Percutaneous coronary interventions

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; STRONTIUM 90; YTTRIUM 90;

ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BRACHYTHERAPY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HEART DISEASE; HEART INJURY; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; INTRACARDIAC THROMBOSIS; LOG RANK TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; STATISTICAL ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ASPIRIN; BRACHYTHERAPY; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STENTS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846338424     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.008     Document Type: Article

References (27)

1. Mercado N., Boersma E., Wijns W., et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 38 (2001) 645-652
2. Teirstein P.S., Massullo V., Jani S., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336 (1997) 1697-1703
3. Waksman R., White R.L., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101 (2000) 2165-2171
4. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344 (2001) 250-256
5. Kleinman N.S.C.R. Results from late-breaking clinical trials at ACCIS 2000 and ACC 2000. J Am Coll Cardiol 36 (2000) 310-325
6. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 359 (2002) 551-557
7. Verin V., Popowski Y., de Bruyne B., et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 344 (2001) 243-249
8. Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation 100 (1999) 780-782
9. Cheneau E., Wu Z., Leborgne L., et al. Additional stenting promotes intimal proliferation and compromises the results of intravascular radiation therapy: an intravascular ultrasound study. Am Heart J 146 (2003) 142-145
10. Serruys P.W., Wijns W., Sianos G., et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol 44 (2004) 528-537
11. Sabate M., Pimentel G., Prieto C., et al. Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study. J Am Coll Cardiol 44 (2004) 520-527
12. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 102 (2000) 951-958
13. Grise M.A., Massullo V., Jani S., et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 105 (2002) 2737-2740
14. Waksman R., Ajani A.E., White R.L., et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 103 (2001) 2332-2335
15. Teirstein P.S., Moses J., Casterella P., et al. Late thrombosis after coronary radiation may be eliminated by longer antiplatelet therapy and reduced stenting: the SCRIPPS III results. J Am Coll Cardiol 379 Suppl A (2001) 60A
16. Waksman R., Ajani A.E., White R.L., et al. Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. Am J Cardiol 88 (2001) 425-428
17. Waksman R., Ajani A.E., Pinnow E., et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 106 (2002) 776-778
18. Haase J., Escaned J., van Swijndregt E.M., et al. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn 30 (1993) 104-114
19. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
20. Kornowski R., Bhargava B., Fuchs S., et al. Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (< 20 mm) stents. J Am Coll Cardiol 35 (2000) 612-618
21. Teirstein P.S., Massullo V., Jani S., et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation 99 (1999) 243-247
22. Holmes DR. Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions (SISR) trial. TCT 2005.
23. Liistro F., Gimelli G., Di Mario C., et al. Late acute thrombosis after coronary brachytherapy: when is the risk over?. Catheter Cardiovasc Interv 54 (2001) 216-218
24. Serruys P.W., Sianos G., van der Giessen W., et al. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study. Eur Heart J 23 (2002) 1351-1359
25. Urban P., Serruys P., Baumgart D., et al. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 24 (2003) 604-612
26. Limpijankit T., Mehran R., Mintz G.S., et al. Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). Am J Cardiol 92 (2003) 315-318
27. Saia F., Sianos G., Hoye A., et al. Long-term outcome of percutaneous coronary interventions following failed beta-brachytherapy. J Invasive Cardiol 16 (2004) 60-64